Exagen Inc expected to post a loss of 56 cents a share - Earnings Preview

Exagen

13/05/2023 03:02

* Exagen Inc  XGN.OQ   XGN.O  is expected to show a fall in
quarterly revenue when it reports  results on May 15. 
    * The Vista California-based  company is expected to report 
a
9.6% decrease in revenue to $9.4 million from $10.39 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. The company's guidance on March 20 2023, for
the period ended March 31, was for revenue between $9.20 million
and $9.70 million.
    * ​Refinitiv's mean analyst estimate for Exagen Inc is for a
loss
of 56 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Exagen Inc
is
$6.5​, above​ its last closing price of $2.93. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.81       -0.78      -0.83     Missed  -6.4
 Sep. 30 2022  -0.73       -0.73      -0.47     Beat    35.6
 Jun. 30 2022  -0.57       -0.57      -0.78     Missed  -36.8​
 Mar. 31 2022  -0.61       -0.61      -0.60     Beat    1.4
 ​​Dec.        -0.44       -0.50      -0.42     Beat    15.4
 31 2021                                                
 Sep. 30 2021  -0.47       -0.46      -0.42     Beat    8.7​
 Jun. 30 2021  -0.47       -0.44      -0.38     Beat    13
 Mar. 31 2021  -0.47       -0.47      -0.48     Missed  -2.3
 This summary was machine generated May 13 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated